In silico exploration of phytochemicals for GLP-1 receptor agonists for the treatment of type 2 diabetes
Leah Joseph, MD, FACP , at JosephCareRX provides expert care
Watch for nausea, lightheadedness, or blood sugar changes in the meantime
Take patients with diabetic neuropathy - their gastric transit time actually got faster with liraglutide (from 1:12:36 to 0:48:40 hours), though the change wasn't huge [19]
Our providers will work with you to minimize any discomfort and maximize your results
Aging populations, sedentary lifestyles, and urbanization contribute to increasing rates of metabolic disorders, creating a larger target patient pool for GLP-1 therapies